Mar 23, 2022 / 01:00PM GMT
Paul Richard Knight - KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst
Good morning. This is Paul Knight, Analyst at Keybanc Capital Markets on the Life Science Industry. We have with us today West Pharmaceutical, Eric Green, CEO; Bernard Birkett, Chief Financial Officer; and Quintin Lai, who's Director of Investor Relations.
The format is going to be -- I think Eric is going to have a few opening comments. If you have questions, you can ask them any time. There's a chat you can put those questions into or on my e-mail [email protected].
And with that, Eric, we appreciate your time today. And I'll let you start it off.
Eric M. Green - West Pharmaceutical Services, Inc. - Chair, President & CEO
Yes. Great. Well, good morning, Paul, and good morning, everyone. Thank you for the invitation to be able to come together and talk about West and where we are, but more importantly, where we're going. It's an exciting time here at West. Obviously, we'll probably talk a little bit further in the Q&A session around the
West Pharmaceutical Services Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers